These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 22089787

  • 41. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD.
    Transplantation; 2009 Apr 27; 87(8):1232-9. PubMed ID: 19384172
    [Abstract] [Full Text] [Related]

  • 42. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    McCarthy ET, Sharma M, Savin VJ.
    Clin J Am Soc Nephrol; 2010 Nov 27; 5(11):2115-21. PubMed ID: 20966123
    [Abstract] [Full Text] [Related]

  • 43. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
    Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, Koziell A, Zaritsky JJ.
    Pediatr Nephrol; 2019 Nov 27; 34(11):2343-2350. PubMed ID: 31250206
    [Abstract] [Full Text] [Related]

  • 44. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH, Lee JH, Park GY, Lim JH, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.
    Ren Fail; 2014 May 27; 36(4):623-6. PubMed ID: 24502587
    [Abstract] [Full Text] [Related]

  • 45. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
    Sozeri B, Mir S, Mutlubas F, Sen S.
    Saudi J Kidney Dis Transpl; 2010 Jan 27; 21(1):87-92. PubMed ID: 20061699
    [Abstract] [Full Text] [Related]

  • 46. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis.
    Fencl F, Vondrák K, Rosík T, Zieg J, Chadimová M, Háček J, Dušek J, Seeman T.
    Minerva Pediatr; 2016 Oct 27; 68(5):348-54. PubMed ID: 26041001
    [Abstract] [Full Text] [Related]

  • 47. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec 27; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

  • 48. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 49. Recurrence of focal glomerulosclerosis in post-renal transplant recipients: report of two cases.
    Akioka K, Okamoto M, Ushigome H, Kadotani Y, Ogino S, Higuchi A, Wakabayashi Y, Kaihara S, Yoshimura N.
    Transplant Proc; 2004 Sep 15; 36(7):2167-8. PubMed ID: 15518788
    [Abstract] [Full Text] [Related]

  • 50. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
    Shibasaki Y, Nishiue T, Masaki H, Matsubara H, Iwasaka T.
    Nihon Rinsho; 2002 Oct 15; 60(10):1992-8. PubMed ID: 12397697
    [Abstract] [Full Text] [Related]

  • 51. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A, Kaori S, Takei T, Nitta K.
    CEN Case Rep; 2020 Aug 15; 9(3):195-199. PubMed ID: 31997159
    [Abstract] [Full Text] [Related]

  • 52. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
    Turk J Pediatr; 2010 Aug 15; 52(3):255-61. PubMed ID: 20718182
    [Abstract] [Full Text] [Related]

  • 53. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
    Solomon S, Zolotnitskaya A, Del Rio M.
    Pediatr Transplant; 2019 Jun 15; 23(4):e13413. PubMed ID: 30973669
    [Abstract] [Full Text] [Related]

  • 54. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
    Seso Simić D, Slavicek J, Bubić Filipi L, Puretić Z, Kes P.
    Acta Med Croatica; 2003 Jun 15; 57(1):53-6. PubMed ID: 12876864
    [Abstract] [Full Text] [Related]

  • 55. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H.
    Transpl Int; 2005 Apr 15; 18(4):458-60. PubMed ID: 15773967
    [Abstract] [Full Text] [Related]

  • 56. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 57. Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function.
    Sener A, Bella AJ, Nguan C, Luke PP, House AA.
    Clin Transplant; 2009 Nov 15; 23(1):96-100. PubMed ID: 19200221
    [Abstract] [Full Text] [Related]

  • 58. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: a case report.
    Couloures K, Pepkowitz SH, Goldfinger D, Kamil ES, Puliyanda DP.
    Pediatr Transplant; 2006 Dec 15; 10(8):962-5. PubMed ID: 17096767
    [Abstract] [Full Text] [Related]

  • 59. Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation.
    Dharnidharka VR, Scobell RR, Kallash M, Davies AJG, Marchesani N, Maltenfort MG, Walther L, Kelton M, Bock M, Blanchette E, Stone HK, Gluck C, Hullekes F, Riella LV, Smoyer WE, Mitsnefes M, Dixon BP, Flynn JT, Somers MJG, Forrest CB, Furth S, Denburg MR.
    Pediatr Nephrol; 2024 Nov 15; 39(11):3317-3331. PubMed ID: 39001911
    [Abstract] [Full Text] [Related]

  • 60. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK, Varma PP, Baliga KV.
    J Assoc Physicians India; 1999 Feb 15; 47(2):180-2. PubMed ID: 10999084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.